Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Vindya Nilakshi Wijesinghe, Isra Ahmad Farouk, Nur Zawanah Zabidi, Ashwini Puniyamurti, Wee Sim Choo & Sunil Kumar Lal. (2021) Current vaccine approaches and emerging strategies against herpes simplex virus (HSV). Expert Review of Vaccines 20:9, pages 1077-1096.
Read now
Read now
Nathalie Garçon & Alberta Di Pasquale. (2017) From discovery to licensure, the Adjuvant System story. Human Vaccines & Immunotherapeutics 13:1, pages 19-33.
Read now
Read now
Sita Awasthi, Carolyn Shaw & Harvey Friedman. (2014) Improving immunogenicity and efficacy of vaccines for genital herpes containing herpes simplex virus glycoprotein D. Expert Review of Vaccines 13:12, pages 1475-1488.
Read now
Read now
Shane C McAllister & Mark R Schleiss. (2014) Prospects and perspectives for development of a vaccine against herpes simplex virus infections. Expert Review of Vaccines 13:11, pages 1349-1360.
Read now
Read now
William P Halford. (2014) Antigenic breadth: a missing ingredient in HSV-2 subunit vaccines?. Expert Review of Vaccines 13:6, pages 691-710.
Read now
Read now
Articles from other publishers (13)
Marija Barbateskovic, Sarah Louise Klingenberg, Sara Russo Krauss, Dezhao Kong, Zhangtong Wu, Sesilje B. Petersen, Mette Kenfelt & Christian Gluud. (2023) Concentrations, Number of Doses, and Formulations of Aluminium Adjuvants in Vaccines: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Clinical Trials. Vaccines 11:12, pages 1763.
Crossref
Crossref
Md Sadique Hussain, Gaurav Gupta, Vijaya Paul Samuel, Waleed Hassan Almalki, Imran Kazmi, Sami I. Alzarea, Shakir Saleem, Ruqaiyah Khan, Najla Altwaijry, Samir Patel, Archita Patel, Sachin Kumar Singh & Kamal Dua. (2023) Immunopathology of herpes simplex virus‐associated neuroinflammation: Unveiling the mysteries. Reviews in Medical Virology.
Crossref
Crossref
Abu Tayab Moin, Mohammad Al-baruni Chowdhury, Sumaiya Hafiz Riana, Md. Asad Ullah, Yusha Araf, Bishajit Sarkar & Abdullah Mohammad Shohael. (2021) An Updated Overview of Herpes Simplex Virus-1 Infection: Insights from Origin to Mitigation Measures. Electronic Journal of General Medicine 18:4, pages em299.
Crossref
Crossref
Yan Yan, Kai Hu, Ming Fu, Xu Deng, Sukun Luo, Lina Tong, Xinmeng Guan, Siyi He, Chang Li, Wei Jin, Tao Du, Zifeng Zheng, Mudan Zhang, Yalan Liu & Qinxue Hu. (2021) CCL19 and CCL28 Assist Herpes Simplex Virus 2 Glycoprotein D To Induce Protective Systemic Immunity against Genital Viral Challenge. mSphere 6:2.
Crossref
Crossref
Anthony C. Ike, Chisom J. Onu, Chukwuebuka M. Ononugbo, Eleazar E. Reward & Sophia O. Muo. (2020) Immune Response to Herpes Simplex Virus Infection and Vaccine Development. Vaccines 8:2, pages 302.
Crossref
Crossref
Carol M Kao, Jessica Goymer, Lip Nam Loh, Aakash Mahant, Clare Burn Aschner & Betsy C Herold. (2020) Murine Model of Maternal Immunization Demonstrates Protective Role for Antibodies That Mediate Antibody-Dependent Cellular Cytotoxicity in Protecting Neonates From Herpes Simplex Virus Type 1 and Type 2. The Journal of Infectious Diseases 221:5, pages 729-738.
Crossref
Crossref
Rana Jahanban‐Esfahlan, Khaled Seidi, Maryam Majidinia, Ansar Karimian, Bahman Yousefi, Seyed Mohammad Nabavi, Akram Astani, Ioana Berindan‐Neagoe, Diana Gulei, Francesca Fallarino, Marco Gargaro, Giorgia Manni, Matteo Pirro, Suowen Xu, Mahmoud Sadeghi, Seyed Fazel Nabavi & Samira Shirooie. (2019) Toll‐like receptors as novel therapeutic targets for herpes simplex virus infection. Reviews in Medical Virology.
Crossref
Crossref
Yeye Guo, Xu Zhang, Tianhao Wu, Xing Hu, Juan Su & Xiang Chen. (2019) Autophagy in Skin Diseases. Dermatology 235:5, pages 380-389.
Crossref
Crossref
Michael T. Hensel, Jason D. Marshall, Michael R. Dorwart, Darren S. Heeke, Eileen Rao, Padmaja Tummala, Li Yu, Gary H. Cohen, Roselyn J. Eisenberg & Derek D. Sloan. (2017) Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir. Journal of Virology 91:9.
Crossref
Crossref
Yan Yan, Kai Hu, Xu Deng, Xinmeng Guan, Sukun Luo, Lina Tong, Tao Du, Ming Fu, Mudan Zhang, Yalan Liu & Qinxue Hu. (2015) Immunization with HSV-2 gB-CCL19 Fusion Constructs Protects Mice against Lethal Vaginal Challenge. The Journal of Immunology 195:1, pages 329-338.
Crossref
Crossref
Christopher Petro, Pablo A González, Natalia Cheshenko, Thomas Jandl, Nazanin Khajoueinejad, Angèle Bénard, Mayami Sengupta, Betsy C Herold & William R JacobsJrJr. (2015) Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease. eLife 4.
Crossref
Crossref
Petra C.F. Oyston. 2015. Molecular Medical Microbiology. Molecular Medical Microbiology
627
634
.
Y-Y Wang, A Kannan, K L Nunn, M A Murphy, D B Subramani, T Moench, R Cone & S K Lai. (2014) IgG in cervicovaginal mucus traps HSV and prevents vaginal Herpes infections. Mucosal Immunology 7:5, pages 1036-1044.
Crossref
Crossref